Series A Funding
Singapore’s Esco Secures $200M in Oversubscribed Series A to Develop Cell and Gene Therapy Equipments
2021-05-28
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
2021-03-02
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115